Search

everythinglearnresearchcommunity

for

Search:↓

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

The study suggests using a score of 11 on the mFG scale to diagnose hirsutism in Turkish women, with adjustments for age, skin type, and family history.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

Hirsutism affects many women and is managed with a combination of medical treatments and hair removal, tailored to individual needs.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Efficient PCOS screening is crucial for early detection, with lifestyle factors like fruit intake potentially aiding prevention.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Checking the chin, thighs, upper lip, or lower abdomen is enough to predict hirsutism.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Combined finasteride and spironolactone therapy significantly improves quality of life in women with PCOS.

More body hair in young Australian women is linked to higher androstenedione levels.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Hirsutism moderately affects the quality of life for most women, linked to condition severity.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.